Ubs Group Ag Gilead Sciences, Inc. Call Options Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

Call Options

31 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$66.59 - $83.99 $6.79 Million - $8.57 Million	102,000 Added 24.98%	510,288 $42.8 Million
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $3.61 Million - $4.16 Million	57,088 Added 16.26%	408,288 $28 Million
Q1 2024 May 13, 2024	SELL	$71.58 - $87.29 $17.2 Million - $21 Million	-240,700 Reduced 40.67%	351,200 $25.7 Million
Q4 2023 Feb 09, 2024	SELL	$73.27 - $83.09 $2.04 Million - $2.31 Million	-27,800 Reduced 4.49%	591,900 $47.9 Million
Q3 2023 Nov 09, 2023	BUY	$73.94 - $80.67 $5.21 Million - $5.68 Million	70,400 Added 12.82%	619,700 $46.4 Million
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $16.4 Million - $18.8 Million	-216,400 Reduced 28.26%	549,300 $42.3 Million
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $3.94 Million - $4.48 Million	50,900 Added 7.12%	765,700 $63.5 Million
Q4 2022 Feb 08, 2023	BUY	$62.32 - $89.47 $21.5 Million - $30.9 Million	344,900 Added 93.24%	714,800 $61.4 Million
Q3 2022 Nov 10, 2022	BUY	$59.54 - $68.01 $6.49 Million - $7.41 Million	109,000 Added 41.78%	369,900 $22.8 Million
Q2 2022 Aug 10, 2022	SELL	$57.72 - $65.01 $19.6 Million - $22.1 Million	-339,400 Reduced 56.54%	260,900 $16.1 Million
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $14.4 Million - $18 Million	-248,300 Reduced 29.26%	600,300 $35.7 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $199,895 - $226,884	3,081 Added 0.36%	848,600 $61.6 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $26.5 Million - $28.6 Million	391,606 Added 86.27%	845,519 $59.1 Million
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $4.34 Million - $4.75 Million	-68,439 Reduced 13.1%	453,913 $31.3 Million
Q1 2021 May 12, 2021	BUY	$60.0 - $68.46 $1.49 Million - $1.7 Million	24,852 Added 5.0%	522,352 $33.8 Million
Q4 2020 Feb 11, 2021	BUY	$56.65 - $64.55 $1.62 Million - $1.85 Million	28,640 Added 6.11%	497,500 $29 Million
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $714,150 - $897,920	11,500 Added 2.51%	468,860 $29.6 Million
Q2 2020 Jul 31, 2020	SELL	$72.34 - $84.0 $6.44 Million - $7.48 Million	-89,012 Reduced 16.29%	457,360 $35.2 Million
Q1 2020 May 01, 2020	BUY	$62.63 - $80.22 $9.09 Million - $11.6 Million	145,172 Added 36.18%	546,372 $40.8 Million
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $9.91 Million - $10.9 Million	160,900 Added 66.96%	401,200 $26.1 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $2.93 Million - $3.23 Million	46,800 Added 24.19%	240,300 $15.2 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $3.14 Million - $3.52 Million	-50,720 Reduced 20.77%	193,500 $13.1 Million
Q1 2019 May 14, 2019	SELL	$62.53 - $70.05 $22.5 Million - $25.2 Million	-359,380 Reduced 59.54%	244,220 $15.9 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $6.9 Million - $9 Million	113,900 Added 23.26%	603,600 $37.8 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $9.27 Million - $10.3 Million	-129,984 Reduced 20.98%	489,700 $37.8 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $326 Million - $380 Million	-5,021,568 Reduced 89.02%	619,684 $43.9 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $391 Million - $477 Million	5,370,827 Added 1986.07%	5,641,252 $425 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $9.13 Million - $10.7 Million	128,266 Added 90.23%	270,425 $19.4 Million
Q3 2017 Nov 14, 2017	SELL	$72.11 - $85.47 $67.6 Million - $80.2 Million	-938,065 Reduced 86.84%	142,159 $11.5 Million
Q2 2017 Aug 14, 2017	BUY	N/A	546,108 Added 102.25%	1,080,224 $76.5 Million
Q1 2017 Nov 14, 2017	BUY	N/A	534,116	534,116 $36.3 Million

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$10.9 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.4 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$6.9 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.57 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.43 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account